• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Blogs
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Blogs
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Healthy Snacking: Matching Lifestyle with Nutrition

    Vitamins & Minerals: Traditions in Preventive Health

    Fiber Revisited: Closing the Gap

    Green Power for Future Generations

    2019 International Buyers' Guide
    Blogs & Guest Articles
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Tilray Buys Hemp-Foods Company Manitoba Harvest for $318 Million

    Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract

    Health Drives Surge in Alternative, Plant-Based Product Options

    PepsiCo to Acquire CytoSport from Hormel Foods

    Study Shows Collagen Peptides Aid Runners in Injury Recovery
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Tilray Buys Hemp-Foods Company Manitoba Harvest for $318 Million

    Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract

    Health Drives Surge in Alternative, Plant-Based Product Options

    PepsiCo to Acquire CytoSport from Hormel Foods

    Study Shows Collagen Peptides Aid Runners in Injury Recovery
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Tilray Buys Hemp-Foods Company Manitoba Harvest for $318 Million

    Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract

    Health Drives Surge in Alternative, Plant-Based Product Options

    PepsiCo to Acquire CytoSport from Hormel Foods

    Study Shows Collagen Peptides Aid Runners in Injury Recovery
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Study Shows Collagen Peptides Aid Runners in Injury Recovery

    Podcast: Talking Hemp & CBD 101 with AHPA’s Jane Wilson

    Afrigetics Botanicals Sponsors Bulbine through ABC’s Adopt-an-Herb Program

    Research on Stratum Eggshell Membrane Explores Benefits for Cartilage Protection

    New Monograph on Centella asiatica Looks to Expand Use and Applications
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    PLT Health Solutions

    Barrington Nutritionals

    Watson Inc.

    Herbally Yours

    BatchMaster Software, Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Herbally Yours

    PLT Health Solutions

    Barrington Nutritionals

    Watson Inc.

    Shanghai Freemen
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Political Disruption Presents Opportunity for Industry

    How can the regulatory framework be improved in order to benefit business and consumers?

    Related CONTENT
    • Emerging Challenges in the Cosmetics Market
    • State of the Industry Update & Outlook for 2017
    • FDA to Make Adverse Event Report Data Public
    • FDA Approves Health Claim for Resistant Starch and Reduced Diabetes Risk
    • NPA to Host 2017 Natural Products Day on March 22
    Todd Harrison, Venable04.03.17
    The U.S. election in November was certainly a surprise and ended one of the most controversial and disruptive elections in recent memory. The aftermath has been even more disruptive. Indeed, we have rarely seen a president so committed to being disruptive, and if the first three months of the Trump presidency are any indication, these trends will continue.

    Having the federal bureaucracy shaken up may or may not be good news to individuals or companies, but there is little doubt that disruption can either be positive or negative. Certainly, overly burdensome or nonsensical regulatory schemes are of themselves disruptive, especially if they deny access to products that promote overall health and well-being. In this regard, the present regulatory structure for dietary supplements and topical products is disruptive to the overall health and well-being of consumers in the U.S. 

    With regard to dietary supplements, the passage of the Dietary Supplement Health and Education Act (DSHEA) was considered disruptive legislation that tied the hands of the FDA. This myth persists today. The reality, however, is that over the last 22-plus years, this legislation has become more of a negative disruption by creating a construct that has left very few barriers of entry, stymied innovation—as FDA has learned it has considerable power under DSHEA—and left consumers with less information regarding how to better their overall health.

    Even worse, it creates a situation where it compels company lawyers to push the limits of credulity of the medical food category. Seriously, does anyone believe that individuals with osteoarthritis have a unique nutritional need for polyphenols? Does anyone earnestly believe “helps reduce the appearance of wrinkles” is any different than simply stating “helps reduces wrinkles”? Furthermore, does the claim “helps support normal blood sugar levels,” rather than “helps support already normal blood sugar levels,” make any sense? Does anyone believe that a simple change in the manufacturing method causes a pre-DSHEA dietary ingredient to, suddenly, become a “new” dietary ingredient? Or that changing a standardization level so the dietary supplement can be taken in one large pill, rather than one small pill, cause that ingredient to become a new dietary ingredient?

    Yet, this is exactly what the present regulatory framework does. Does anyone seriously believe that after 22 years, FDA can effectively determine what was on the market prior to Oct. 14, 1994 when documents were stored in boxes and not on computer networks? Should any regulator be able to ask for all the information substantiating a claim and then simply state “our experts disagree” and attempt to force a consent judgment down a company’s throat, because the company cannot make a solid evaluation of the regulator’s evidence? Yet, that is the FTC and state investigatory practice. They take all the information in and the target company gets no feedback. Simply stated, we have a disruptive regulatory state in the natural products industry. I will spare everyone my diatribe on class action lawsuits.  

    Dysfunctional Framework
    These are just a few of the points that a negative disruptive regulatory framework brings to us. Indeed, one could say to be careful what you ask for because you may very well get it. Well, 22-plus years later we have a dysfunctional regulatory framework that wreaks havoc in the marketplace. It deprives consumers of important information regarding a product, because we’ve decided that many of the following purported age-related issues are diseases, including, prediabetes, metabolic syndrome osteoarthritis, obesity, BPH, prehypertension, and, yes, even diabetes and hypertension that do not require medication to control. A natural topical product cannot even say “soothes diaper rash” if it doesn’t contain one of the enumerated topical OTC drugs for the treatment of diaper rash. Yet, products making these claims are readily available on the Internet. Many of them are legitimate yet others are sold by unscrupulous marketers that prey on the ignorance of consumers and stay ahead of federal and state agencies while creating a substantial stain on the natural products industry.

    Unfortunately, we have developed a regulatory system that fails to recognize that natural medicine helps individuals whether the product is ingested or applied topically. Instead, we have created a system that demands expensive clinical trials for ingredients that are no longer patentable because their uses are not novel, making it unlikely such a trial will be conducted. It is a system in which courts are now allowing plaintiff attorneys to file lawsuits under state deceptive trade practices if a particular structure/function or cosmetic claim might be considered a disease claim based on the preamble to a final rule or an FDA warning letter. This is true even if the company receiving the warning letter has a legitimate position that the claim is not an impermissible disease claim.

    Examples include “helps alleviate sore joints” and “helps alleviate nighttime trips in men over the age of 50” in which both claims are related to the natural progression of age. The central fact here is that as we age, our joints ache. It is part of life, but we treat it as if it were a disease. For men over 50, getting up once or twice nightly is not uncommon, and is part of the well-accepted fact that prostates grow at this stage in life. Yet, it is perceived as a disease. It is a system that has not kept up with what the public wants and legitimate companies can provide. 

    Innovation and legitimate products have become beholden to the constraints of the regulatory system and a heavy reliance on lawyers to bend and twist words to help communicate the real purpose of the product without running afoul of the system. It has created a vast number of gray areas between what is and what is not a permissible claim. We use claims such as “helps support blood pressure already in the normal range” when, in fact, if you have 120/80 blood pressure you do not need this product. However, if you are pre-hypertensive or at stage 1 where dietary intervention and exercise is always the initial intervention, including use of targeted dietary supplements that can help lower blood pressure sensitive to dietary intervention, this claim cannot be communicated to consumers by a company.

    Probably, the more absurd situation I alluded to previously is topical natural products that cannot even make the claim “helps soothe diaper rash” unless it contains specific permitted active ingredients covered by the OTC Drug Monograph system. This makes little sense and is a waste of FDA’s enforcement time to take issue with such products, especially if the claims are substantiated.

    Suggestions for Positive Disruption
    By now you are asking, “How does this relate to the disruptive results of the national election?  Todd, we know the regulatory system is screwed up and it’s not, necessarily, the fault of the regulators.” My point is that for the first time in a very long time, we have an administration that is open to true, positive disruption, and the industry should be thinking how to put a more sane regulatory system in place for both dietary supplements and topical natural products.

    We could create a natural product monograph system and specifically preclude class action lawsuits on claims that are consistent with that monograph. For those products that don’t fit into the monograph, there should be the option to conduct a clinical study on the product, and if the results are positive, the claims should be permissible. We could setup a 510k-like system, as we currently have for medical devices, but for natural products. FDA could review the study and agree whether the study supports the claim. Within this system, we could create a process in which FDA reviews the protocol of the study first (for a reasonable fee), provides feedback, and ultimately signs off on the study design.

    It should not be required to undergo the protocol review process, but if undertaken it is conducted at the company’s own risk, as medical devices do today. Clearly, however, I’m not advocating for the dismantling of DSHEA. Those who are happy with it may continue down that path. Rather, this is a system that could be in addition to DSHEA for those companies desiring to make truthful and non-misleading claims for age-related health conditions and diseases.

    Regardless, there is one amendment to DSHEA we should all agree on. This is to reset the grandfathered date for ingredients under DSHEA; the amendment would require FDA to promulgate a list within one year based on labels provided by the industry. In addition, this amendment should clarify that synthetic botanicals that are truly synthetic versions of natural constituents are permissible dietary ingredients.  

    Finally, we should also revise the civil investigation rules for the FTC to require it to disclose in detail why it believes a company’s claims are not substantiated prior to seeking an action. It should also provide the company adequate time to respond directly to the commissioners tasked with the responsibility of deciding whether to move forward should the company decide not to settle.  

    These few suggestions are not intended to be all encompassing. Rather, they’re intended to be food for thought on how we may bring about disruptive legislation that would actually improve the regulatory framework and benefit American consumers. We have at least two years for out-of-the-box thinking. The question here lays in whether the industry is ready to be disruptive by proposing disruptive legislation that makes sense and will benefit everyone. 


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Metabolic Syndrome
    • Nutritional
    • Medical Food
    • Botanicals
    Related Knowledge Center
    • Quality & Safety
    • Regulations
    • Dietary Supplements
    Suggested For You
    Engredea 2018 Event Info Engredea 2018 Event Info
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation
    Flavors & Colors: A Natural Recipe for Success Flavors & Colors: A Natural Recipe for Success
    Kate Pastor Joins Aker BioMarine as Senior Vice President of Sales Kate Pastor Joins Aker BioMarine as Senior Vice President of Sales
    FDA Nominee Uses Supplements Daily and Promises Access During Tenure FDA Nominee Uses Supplements Daily and Promises Access During Tenure
    Building Foundations for Healthy Living Building Foundations for Healthy Living
    UNPA Offering New GMP Training Course June 27-28 UNPA Offering New GMP Training Course June 27-28
    Dietary Supplement Associations to Host May 10 Seminar Dietary Supplement Associations to Host May 10 Seminar
    NPA Organizes 20th Annual Natural Products Day NPA Organizes 20th Annual Natural Products Day
    FDA Issues GRAS No Objection Letter for SweeGen’s Reb-M Stevia Sweetener FDA Issues GRAS No Objection Letter for SweeGen’s Reb-M Stevia Sweetener
    Establishing Specifications as Required by Dietary Supplement cGMPs Establishing Specifications as Required by Dietary Supplement cGMPs
    Natural Products Association Modernizes Bylaws Natural Products Association Modernizes Bylaws
    NOW Opens 200,000 Square Foot Distribution Facility NOW Opens 200,000 Square Foot Distribution Facility
    GanedenBC30 Receives GRAS Status for Infants GanedenBC30 Receives GRAS Status for Infants
    Understanding GMO Labeling Legislation Understanding GMO Labeling Legislation

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations | Research
      Nuances of the Healthcare Institutional Nutrition Market

      Nuances of the Healthcare Institutional Nutrition Market

      The opportunity for distribution of nutritional products in hospitals, rehabilitation facilities, nursing homes, and home care is growing dramatically.
      By Gregory Stephens, RD, Trish Cadwallader & Sheila Campbell, PhD, RD 01.03.19

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      The Magical Mystery Tour Also Known as Cannabis Sativa

      The Magical Mystery Tour Also Known as Cannabis Sativa

      What’s in the new Farm Bill and what does it mean for hemp and CBD?
      By Todd Harrison & Meryl Nolan, Venable 01.03.19

    • Dietary Supplements | Healthcare Trends | Regulations | World Markets
      Personalized Nutrition: New Opportunities for Product Development

      Personalized Nutrition: New Opportunities for Product Development

      The introduction of effectively targeted solutions has strong potential to improve consumer health and well-being.
      By Joerg Gruenwald, analyze & realize GmbH 01.03.19


    • Cancer Risk | Herbs & Botanicals | Mood Health & Sleep | Quality & Safety | Research | Testing
      Botanical Science: Ginseng for Stress Response & Data Transparency

      Botanical Science: Ginseng for Stress Response & Data Transparency

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly E. Johnson, PhD, American Herbal Products Association 01.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Quality & Safety
      How Do Practitioners Define Dietary Supplement Quality?

      How Do Practitioners Define Dietary Supplement Quality?

      Beyond what’s in a product, quality encompasses everything from science behind a formulation to diligence of staff.
      By Erik Goldman, Holistic Primary Care 12.06.18

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      Availability of CBD Liability Insurance (and Actual Coverage) is Often Scarce

      Availability of CBD Liability Insurance (and Actual Coverage) is Often Scarce

      The wild west of CBD is fraught with perils, not the least of which is buying liability insurance you can rely on.
      By Greg Doherty, Bolton & Company 12.06.18


    • Dietary Supplements | Healthcare Trends | Regulations
      Is Google’s AdSense System Biased Against Dietary Supplements?

      Is Google’s AdSense System Biased Against Dietary Supplements?

      The company lumps drugs and supplements into a single ad category, creating an unwitting bias in favor of pharma.
      By Erik Goldman, Holistic Primary Care 10.01.18

    • Dietary Supplements | Regulations | World Markets
      New Novel Food Regulation: An Overview

      New Novel Food Regulation: An Overview

      Industry reaction has been generally positive, some questions remain.
      By Joerg Gruenwald, analyze & realize ag 09.10.18

    • Bone & Joint Health | Diabetes & Blood Sugar Management | Herbs & Botanicals | Men's Health | Mood Health & Sleep | Quality & Safety | Research | Sports Nutrition
      Botanical Research: Herbal Efficacy & Testing

      Botanical Research: Herbal Efficacy & Testing

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly E. Johnson, PhD, American Herbal Products Association (AHPA) 09.10.18


    • Dietary Supplements | Herbs & Botanicals | Medical Nutrition | Regulations
      Confusion Over Cannabis & The Fate of CBD

      Confusion Over Cannabis & The Fate of CBD

      Fair and reasonable or not, FDA could very well be a major buzzkill in the CBD supplement sector.
      By Erik Goldman, Holistic Primary Care 07.02.18

    • Quality & Safety | Regulations
      Tips & Tricks for Walking the Insurance Application Minefield

      Tips & Tricks for Walking the Insurance Application Minefield

      Product liability insurance applications can be challenging to complete, so companies need to be diligent.
      By Greg Doherty, Bolton & Company 07.02.18

    • Cardiovascular Health | Cognitive Function | Herbs & Botanicals | Mood Health & Sleep | Quality & Safety | Research | Testing
      Botanical Research: Benefits for Cognitive Function, Insomnia & Other Conditions

      Botanical Research: Benefits for Cognitive Function, Insomnia & Other Conditions

      AHPA compiles recent research on botanicals and plant compounds published in peer-reviewed journals.
      By Holly Johnson, PhD, American Herbal Products Association (AHPA) 06.04.18

    • Regulations | World Markets
      Safeguarding Your Intellectual Property for Nutraceuticals

      Safeguarding Your Intellectual Property for Nutraceuticals

      Securing patents and trademarks will help protect your brand and lead to commercial success.
      By Gregory Stephens, Windrose Partners 06.01.18

    • Infant & Children's Health | Regulations | Vitamins | Women's Health
      Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth

      Petition Seeks Health Claim for Vitamin D, Lower Risk of Preterm Birth

      Supplements are affordable, safe, and effective for modifying maternal serum vitamin D levels to improve pregnancy outcomes.
      By Todd Harrison & Michelle Jackson, Venable 06.01.18

    • Regulations | World Markets
      Understanding New Medical Device Regulations

      Understanding New Medical Device Regulations

      Manufacturers should assess whether their products are subject to reclassification and be aware of associated requirements.
      By Joerg Gruenwald, analyze & realize ag 06.01.18

    Breaking News
    • Solabia Earns Halal Certification for Peptones and Hydrolysates
    • Tilray Buys Hemp-Foods Company Manitoba Harvest for $318 Million
    • Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract
    • Health Drives Surge in Alternative, Plant-Based Product Options
    • PepsiCo to Acquire CytoSport from Hormel Foods
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2019

    • Healthy Snacking: Matching Lifestyle with Nutrition
    • Vitamins & Minerals: Traditions in Preventive Health
    • Fiber Revisited: Closing the Gap
    • Green Power for Future Generations
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login